Skip to content
NASDAQ · INSURANCE AGENTS, BROKERS & SERVICE · SMALL CAP

Yuanbao Inc. YB

3 fiscal years on record · CNY · FY2025 reported · SEC filings only
CNY 4.4B
▲ 33.1% YoY
CNY 1.3B
▲ 51.0% YoY
CNY 1.5B
▲ 22.6% YoY
In brief

What this company does

Yuanbao distributes customized insurance products underwritten by partnered insurance carriers, acting as a gateway between insurance consumers and those carriers. In 2023, 2024 and 2025, it served approximately 8.1 million, 13.9 million and 18.2 million insurance consumers, respectively, from all provinces in Chinese mainland. Its principal offices are located in Beijing, China, and it also leases offices in Guangzhou, Hechi, Nanjing and Hong Kong. The insurance products it distributes are categorized into short-term insurance and long-term insurance, depending on whether the policy term is longer than one year. Insurance products available on its platform primarily consist of medical insurance, critical illness insurance, and other short-term and life insurance. Its platform offers medical insurance products that typically cover medical expenses related to outpatient care, diagnostic tests, surgery and hospitalization. Its critical illness insurance products, available on its platform, typically cover a range of medical conditions, including cancer, stroke, heart disease and paralysis.

Written from the business description in Yuanbao Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 30 April 2026. Every sentence was checked against that document before publication.

Growth
CNY 4.4B
Revenue, FY2025 · full 3-year series below
Revenue CNY B Net income CNY B
FY2025 · Revenue 4.4 · Net income 1.3
2B4B202320242025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
30 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 32.2% · Net 29.9%
10%20%30%202320242025
ROE

Not applicable: equity was negative in this period, so return on equity has no meaning.

Each CNY of equity produced 153 cents of profit this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow CNY B
FY2025 · FCF 1.5
0.5B1.0B202320242025

Total assetsCNY 4.7B
EquityCNY 3.3B
CashCNY 860.5M
Current ratio3.91×

Equity funds 72% of total assets.

The 3-year record
3 fiscal years
Every figure from documents filed with the SEC · CNY

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 202520242023
Revenue CNY B4.43.32.0
Operating income CNY B1.40.90.2
EBITDA CNY B···
Income tax CNY B0.10.00.0
Net income CNY B1.30.90.2
Free cash flow CNY B1.51.20.4
EPS, diluted CNY 4.573.19−4.71
Dividend / sh CNY ···
Payout %···
ROE %152.7··
Shares out B·0.11·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Compare

This company against its peers

Provenance
Company facts, as filed
How we verify · 0 failures in 10 reconciliationsAUDITED

Reconciled in 3 of 19 fiscal years. 82 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityInsurance Agents, Brokers & Service
Listed onNASDAQ
Incorporated inoutside the United States — SEC code E9
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2023

Share this section

Download image